Zhitong Finance App News, Jianfeng Group (600668.SH) issued an announcement. Recently, Zhejiang Jianfeng Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for compound topicamide eye drops approved and issued by the State Drug Administration. Topicamide is a synthetic derivative of tropinic acid. It is an M-choline receptor blocker with effects similar to atropine. Phenylephrine is an adrenaline alpha receptor stimulant that has a pupil dilating effect. This product is used to dilate pupils and control paralysis for the purpose of diagnosis and treatment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.